Sparfloxacin
From Wikipedia, the free encyclopedia
Sparfloxacin
|
|
Systematic (IUPAC) name | |
5-amino-1-cyclopropyl-7-[(3R,5S)3,5-dimethylpiperazin- 1-yl]-6,8-difluoro-4-oxo-quinoline-3-carboxylic acid |
|
Identifiers | |
CAS number | 110871-86-8 |
ATC code | J01MA09 |
PubChem | 60464 |
DrugBank | APRD01231 |
Chemical data | |
Formula | C19H22N4F2O3 |
Mol. weight | 392.41 g/mol |
Pharmacokinetic data | |
Bioavailability | 92% |
Protein binding | 45% |
Metabolism | Hepatic glucuronidation Cytochrome P450 system not involved |
Half life | 16 to 30 hours |
Excretion | Fecal (50%) and renal (50%) |
Therapeutic considerations | |
Pregnancy cat. |
C(US) |
Legal status |
℞-only(US) |
Routes | Oral |
Sparfloxacin (spar FLOX a sin), trade names Zagam® and Zagam Respipac, is a fluoroquinolone antibiotic used in the treatment of bacterial infections.
Quinolones (J01M) edit | ||
---|---|---|
Fluoroquinolones: |
Ciprofloxacin, Enoxacin, Fleroxacin, Gatifloxacin, Gemifloxacin, Grepafloxacin, Levofloxacin, Lomefloxacin, Moxifloxacin, Norfloxacin, Ofloxacin, Pefloxacin, Prulifloxacin, Rufloxacin, Sparfloxacin, Temafloxacin, Trovafloxacin, Sitafloxacin |
|
Other quinolones: |
Cinoxacin, Flumequine, Nalidixic acid, Oxolinic acid, Pipemidic acid, Piromidic acid, Rosoxacin |